The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty
NCT ID: NCT06991231
Last Updated: 2025-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
396 participants
INTERVENTIONAL
2025-06-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preop Cooled Radiofrequency Ablation for Total Knee Replacement
NCT03893292
Genicular Radiofrequency Ablation Following Total Knee Arthroplasty
NCT05283889
Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty
NCT01815918
Intra-Articular Catheter Total Knee Arthroplasty
NCT06580899
Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?
NCT00492973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total knee arthroplasty (TKA) + Cryoablation
Patients will receive cryoablation during the two to three weeks prior to the TKA procedure.
Total knee arthroplasty (TKA)
Administered as part of patient standard of care.
Cryoablation
Cryoablation will be administered on the leg of the knee indicated for surgery.
TKA Only
Patients will NOT receive cryoablation prior to the TKA procedure.
Total knee arthroplasty (TKA)
Administered as part of patient standard of care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total knee arthroplasty (TKA)
Administered as part of patient standard of care.
Cryoablation
Cryoablation will be administered on the leg of the knee indicated for surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients have been medically cleared and scheduled for surgery
Exclusion Criteria
* Surgery for fracture, infection, or malignancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua Rozell, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-00306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.